Drug and Food Administration.

In 2011 June, Agilent’s reagent manufacturing facility in Cedar Creek, Texas, was registered with the FDA as a medical gadget establishment.. Agilent’s liquid chromatography and mass spec systems listed seeing that Class I medical devices with FDA Agilent Technologies Inc. Today announced that it provides detailed its Infinity Series 1200 liquid chromatography systems and 6000 Series mass spectrometry systems as Class I medical products with the U.S. Drug and Food Administration. We’re being extremely methodical in bringing this technology to the clinic, while making certain the equipment meets the laboratories’ wants.Related StoriesMalaria parasite hides undetected in the liver for long time before reawakening to cause diseaseResearchers reveal why malaria vaccine provides just moderate security among vaccinated childrenGHIT Fund invests $10.pdf) highlighting the effect of malaria on African businesses, Agence France-Presse reports. Malaria is harmful to business. The disease is in charge of decreased productivity, worker absenteeism and increased health care spending and may negatively impact a company’s reputation, the report said. The report analysed economic impact of malaria prevention and programmes at three companies, which cut overall medical spending in company clinics and reduced absenteeism, AFP notes.